Search results
...Pasithea Therapeutics Announces the First Cohort has Completed the Initial Dosing in its Phase 1...
Morningstar· 4 days agoPAS-004 is being evaluated in a Phase 1 multicenter open label clinical trial (NCT06299839) in patients with MAPK pathway driven advanced solid tumors with a documented RAS, NF1 or RAF mutation ...
NHS trials first personal skin cancer jab that can halve risk of death
The Telegraph via Yahoo News· 2 days agoIt is also undergoing early testing on other cancers. Around 70 Britons are set to take part in a...
Final first responder convicted in Elijah McClain's death to be sentenced
WSB Radio· 2 days agoFormer paramedic Jeremy Cooper is set to be sentenced Friday after being found guilty of criminally...
A Collier deputy testified about his on-the-job fentanyl overdose. Did it really happen?
Naples Daily News via Yahoo News· 3 days agoβThe initial concern leads to true physiologic fight-or-flight response,β he said. Last year,...
Anthos Therapeutics Announces Appointment of Bill Meury as CEO
Morningstar· 6 days agoAnthos Therapeutics, Inc. (Anthos), is a clinical-stage company developing innovative therapies for cardiovascular diseases, founded by Blackstone Life Sciences (BXLS), today announced the appointment ...
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
Benzinga via Yahoo Finance· 4 days agoWednesday, Immutep Limited (NASDAQ:IMMP) released preliminary topline results from Cohort B of the...
Would The "Rule Of Thumb" In The Fallout TV Series Actually Work?
IFLScience· 6 days agoIn the first episode of Amazon's new TV series Fallout, one of the main characters β played by Walton Goggins β mentions a "rule of thumb" about nuclear blasts. The rule, apparently believed ...
Big Pharma's Blockbuster Creation Continues to Disappoint
Mercola· 4 days ago"We are taking this very seriously," Carl Dieffenbach, head of the Division of AIDS at the National Institute of Allergy and Infectious Diseases (NIAID), told Science.3 Although all HIV mRNA ...
Updates in Managing Elderly Patients With Type 2 Diabetes
Medscape· 4 days agoThe management of patients over the age of 75 years with diabetes is discussed in a crucial chapter...
H.C. Wainwright Cuts HOOKIPA Pharma Shares target on Narrower HB-200 Target Population By...
Investing.com· 2 days agoOn Thursday, H.C. Wainwright adjusted its price target for HOOKIPA Pharma Inc. (NASDAQ:HOOK) shares,...